Paras Biopharma - Biologics CDMO - Finland
https://www.parasbiopharma.com/Overview
Mentions in press and media 9
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 4, 2023 | Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression Facilitating Economical Scale-up of Biologics | Biopharma technology development company in the Nordics, maximises recombinant protein expression in its fully-equipped biologics production facility - Finland. OULU, FINLAND, July 4, 2023/EINPresswire.com/ -- The company is pleased to disc... |
| Dec 12, 2022 | Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics” | Paras Biopharmaceuticals Finland Oy Paras Biopharmaceuticals revealed the company has streamlined & enhanced its business activities with the establishment of a division called Paras Biologics. OULU, FINLAND, December 12, 2022 /EINPress... |
| Dec 12, 2022 | Paras Biopharma Streamlines Offerings as "Biologics CDMO" and Biosimilar Co-Development as "Paras Biologics" | Paras Biopharmaceuticals Finland Oy today revealed that the company has streamlined and enhanced its business activities with the establishment of a division called, Paras Biologics. In addition to its existing biologics CDMO activities and... |
| Nov 29, 2022 | Paras Biopharmaceuticals is Highly Recommended for Biologics CDMO – Development, Scale-up & Production | OULU, FINLAND, November 29, 2022 /EINPresswire.com/ -- Paras Biopharmaceuticals is pleased to announce that the company has been highly recommended for its Biologics CDMO – development / scale-up and production capabilities. The Paras Bioph... |
| Sep 1, 2022 | Paras Biopharmaceuticals Finland identified as one of the Fastest Growing Companies in the Nordic Biotechnology Industry | Paras Biopharmaceuticals Finland Oy Company has a strong track record of offering end-to-end Biologics CDMO Services, developing complex biologics, inc development & licensing of biosimilars. OULU, FINLAND, September 1, 2022 /EINPresswi... |
| May 3, 2022 | Paras Biopharmaceuticals Finland Oy – Exploring Reverse Merger Opportunity | Paras Biopharmaceuticals Finland Oy is seeking appropriate interest on a Reverse Merger to release its potential. OULU, FINLAND, May 3, 2022 /EINPresswire.com/ -- Paras Biopharmaceuticals Finland Oy with a strong track record of developing ... |
| Mar 29, 2022 | Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland Oy | Pleased to announce that from Q3-2022, company will be in a position to offer an expanded biologics CDMO capacity to European, USA & Canadian groups. OULU, FINLAND, March 29, 2022 /EINPresswire.com/ -- Increased capacity offering comes ... |
| Mar 29, 2022 | Expansion of Biologics CDMO & Manufacturing Capacity Offerings at Paras Biopharmaceuticals Finland Oy | It is pleased to announce that from Q3-2022, company will be in a position to offer an expanded biologics CDMO capacity to European, USA & Canadian groups. OULU, FINLAND, March 29, 2022 /EINPresswire.com/ -- Increased capacity offering ... |
Reviews 0
FAQ about Paras Biopharma - Biologics CDMO - Finland
When was Paras Biopharma - Biologics CDMO - Finland founded?
Paras Biopharma - Biologics CDMO - Finland was founded in 2012.
What has the press written about Paras Biopharma - Biologics CDMO - Finland?
Parsers VC has collected 9 articles mentioning Paras Biopharma - Biologics CDMO - Finland, among them “Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression Facilitating Economical Scale-up of Biologics” (Jul 4, 2023) and “Paras Biopharma Streamlines Offerings as “Biologics CDMO” and Biosimilar Co-Development as “Paras Biologics”” (Dec 12, 2022).
Is Paras Biopharma - Biologics CDMO - Finland still active?
Yes, Paras Biopharma - Biologics CDMO - Finland is active; its latest activity on Parsers VC dates from Jun 27, 2024.